Detalhe da pesquisa
1.
Mass Spectrometry-Based Assessment of M-protein in Peripheral Blood During Maintenance Therapy in Multiple Myeloma.
Blood
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713888
2.
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma.
Lancet Oncol
; 25(5): e205-e216, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697166
3.
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial.
Lancet Oncol
; 24(2): 139-150, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642080
4.
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.
Br J Haematol
; 203(5): 792-802, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37691005
5.
Measurable residual disease in peripheral blood in myeloma: dream or reality.
Curr Opin Oncol
; 35(6): 574-580, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37621165
6.
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.
Eur J Haematol
; 110(5): 564-570, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36726221
7.
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma.
Blood
; 136(22): 2513-2523, 2020 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735641
8.
Fair Allocation of Scarce CAR T-Cell Therapies for Relapsed/Refractory Multiple Myeloma.
JAMA
; 2023 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523170
9.
Bendamustine-induced nephrogenic diabetes insipidusâ©.
Clin Nephrol
; 87 (2017)(1): 47-50, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27719738
10.
Sex differences in outcomes in multiple myeloma.
Br J Haematol
; 192(3): e66-e69, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216365
11.
Recommendations for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy.
JAMA
; 326(11): 1058-1059, 2021 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34546311
12.
Clinician attitudes and practices toward measurable residual disease in multiple myeloma.
Br J Haematol
; 190(3): 470-472, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32506429
13.
Risk Factors, Diagnosis, Management, and Outcome of Splanchnic Vein Thrombosis: A Retrospective Analysis.
Semin Thromb Hemost
; 41(5): 503-13, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26080303
14.
Measurable Residual Disease and Decision-Making in Multiple Myeloma.
Hematol Oncol Clin North Am
; 38(2): 477-495, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184470
15.
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
Clin Lymphoma Myeloma Leuk
; 24(2): 83-93, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827881
16.
Panel Interview of ONcology practices with Emergent Experience of teclistamab in the Real world: the TecPIONEER Study.
Curr Med Res Opin
; : 1-6, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38745451
17.
Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational study.
Breast Cancer Res Treat
; 139(3): 821-31, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23760856
18.
Clinician preferences on treatment of smoldering myeloma: a cross-sectional survey.
EClinicalMedicine
; 65: 102272, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38046471
19.
Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma.
Blood Adv
; 7(19): 5703-5712, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763537
20.
Knowing the unknowns in high risk multiple myeloma.
Blood Rev
; 51: 100887, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34479756